A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency

Chatelain, P; Malievskiy, O; Radziuk, K; Senatorova, G; Abdou, MO; Vlachopapadopoulou, E; Skorodok, Y; Peterkova, V; Leff, JA; Beckert, M

Chatelain, P (reprint author), Univ Claude Bernard Lyon 1, Coll Paediat, 5 Chemin Montlouis, F-69230 St Genis Laval, France.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017; 102 (5): 1673

Abstract

Context: TransCon Growth Hormone (GH) (Ascendis Pharma) is a long-acting recombinant sustained-release human GH prodrug in development for children wi......

Full Text Link